Xeomin injections for focal hand muscle spasms
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This trial tests incobotulinumtoxinA (Xeomin) injections to reduce focal hand dystonia—unwanted muscle tightening in the hand. You may be able to join whether you’ve had this condition before or have tried similar injections in the past, as long as certain safety rules are met.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and can sign consent to join
- A neurologist specializing in movement disorders has diagnosed you with focal hand dystonia
- You can follow the study visits and instructions for about 12 weeks
- If you can become pregnant: you agree to use effective birth control during treatment
- You do not have other nerve or brain/spinal problems in the affected arm besides dystonia (for example spasticity)
- You are not pregnant or breastfeeding, and you have no allergy to Xeomin or similar botulinum toxin medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining Botox with non-drug therapies (like physical therapy) helps treat spasticity, which is tight or stiff muscles. It may be a good option if your doctor has already recommended both Botox and other treatments.
This trial tests a new type of botulinum toxin (DaxibotulinumtoxinA) for people with eyelid or facial muscle spasms. It aims to see if it works better or lasts longer than current treatments.
This study tests botulinum toxin (a medication that relaxes muscles) to treat various involuntary movements like tremors, muscle spasms, or uncontrolled facial movements. The goal is to see if this treatment can reduce your symptoms and improve your quality of life.
This trial compares using ultrasound to guide Botox injections versus the usual method without ultrasound, to see if it improves outcomes for people with cervical dystonia.
This trial tests a new botulinum toxin medication (IPN10200) for adults with cervical dystonia, a condition that causes painful muscle spasms in the neck and shoulders. It aims to see if the treatment is safe and effective in reducing symptoms.
This trial tests a new botulinum toxin injection for people with disruptive eyelid spasms (blepharospasm). It may offer longer-lasting relief with potentially fewer side effects for those who currently use other botulinum toxin injections.
Hear when a new Focal Hand Dystonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.